News
-
-
PRESS RELEASE
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026 -
-
PRESS RELEASE
CORRECTION FROM SOURCE: Early Warning News Release Regarding the Acquisition of Over 10% of the Common Shares of Alset AI Ventures Inc.
Alset AI Ventures Inc. announces acquisition of 1,807,153 common shares by Mr. Randy Gilling. The Acquiror now holds 10.82% of the company's shares. More details in the press release -
-
-
-
-
PRESS RELEASE
Carcetti Announces Total Gross Proceeds From Financing of Approximately $492 Million Comprised of Upsized Bought Deal Private Placement of $437 Million and Concurrent Non-Brokered Private Placement of Approximately $55 Million
Carcetti Capital Corp. announces an increase in the size of its bought deal private placement offering to approximately $437 million and amendment of terms. Company to acquire Hemlo Gold Mine in Ontario -
